1995
DOI: 10.1016/0165-4608(94)00148-5
|View full text |Cite
|
Sign up to set email alerts
|

Involvement of chromosome 22 in ependymomas

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
27
0

Year Published

1996
1996
2005
2005

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 36 publications
(30 citation statements)
references
References 23 publications
3
27
0
Order By: Relevance
“…[5][6][7][8][9][10][11][12]14,15 No previous genetic studies have focused specifically on the clear cell variant of ependymoma. Like NF2, DAL-1 (18p11.3) is a member of the protein 4.1 superfamily, a group of functionally related proteins with homologous transmembrane proteinbinding domains.…”
Section: Radiologic Featuresmentioning
confidence: 99%
See 1 more Smart Citation
“…[5][6][7][8][9][10][11][12]14,15 No previous genetic studies have focused specifically on the clear cell variant of ependymoma. Like NF2, DAL-1 (18p11.3) is a member of the protein 4.1 superfamily, a group of functionally related proteins with homologous transmembrane proteinbinding domains.…”
Section: Radiologic Featuresmentioning
confidence: 99%
“…Clearly distinct from astrocytomas and oligodendrogliomas at the molecular level, the most frequently reported abnormality is deletion of chromosome 22. [5][6][7][8][9][10][11][12][13][14][15] Gains of chromosome 1q (16 -18) and losses involving chromosomes 22q (16), 6q (19), and 17p (11) appear to be particularly prevalent in pediatric examples. In a recent study by Singh et al, NF2 and DAL-1, two members of the protein 4.1 superfamily, were implicated in the pathogenesis of ependymomas.…”
mentioning
confidence: 99%
“…The present study has shown a loss of chromosomal region in 22q in a non-NF2 family with ependymoma, supporting a recently proposed perspective for a pathogenesis of rare familial ependymomas (Bijlsma et al, 1995;Ransom et al, 1992;Weremowicz et al, 1992;Wernicke et al, 1995). Although we could not define the exact locus of the responsible gene in this study, our results suggest that 22q deletions could play an important role in the pathogenesis of ependymomas.…”
Section: Discussionmentioning
confidence: 34%
“…Because type-2 neurofibromatosis is caused by a single NF2 gene mutation, and their associated ependymoma usually represent a loss of heterozygosity in the NF2 gene locus on chromosome 22, significant contribution of this gene for the pathogenesis of ependymoma has been proposed. Those studies have reported several cytogenetic alterations in ependymomas, among which deletions or translocations involving chromosome 22q have been the most frequent changes (Bijlsma et al, 1995;Ransom et al, 1992;Weremowicz et al, 1992;Wernicke et al, 1995). However, there is considerable variability in the frequency of allelic losses involving chromosome 22q in various studies.…”
Section: Discussionmentioning
confidence: 99%
“…Whereas ependymomas occur in both children and adults, subependymomas and myxopapillary ependymomas are more common in adults. 267 The CGAP website identifies 106 ependymoma karyotypes 1,22,50,62,64,83,92,117,161,175,207,209,225,227,257,270,278,281,293,294 (also reviewed by Mazewski,et al 161 ). The karyotypes described are predominantly normal, and when abnormal are near-diploid, and are characterized by gains and losses of entire chromosomes.…”
Section: Neurosurg Focus / Volume 19 / November 2005mentioning
confidence: 99%